Healthcare

K2 Therapeutics, a Singapore-based biotechnology company, has raised $50 million in seed financing from MPM BioImpact, the U.S. investment firm that founded the company in 2024.

China's Ant Group, the operator of Alipay, has upgraded its physician platform "Haodf for Doctor" into "AQ for Doctor," an AI-powered workstation for physicians covering online consultations, patient management, clinical decision support, and medical research.

Japan Investment Corporation (JIC) will invest JPY2 billion ($12.7 million) in Red No. 1 Healthcare Investment Limited Partnership, which focuses on biotech, medical devices, and healthcare services startups.

Malaysia's Qmed Asia and United States chipmaker Intel will cooperate to develop a unified patient monitoring platform for hospitals, combining Intel's Patient Monitoring Hub Reference Implementation with Qmed Asia's healthcare software to consolidate fragmented bedside data into a centralized Smart Ward dashboard.

Catalytic Capital for Climate and Health (C3H), a catalytic investment vehicle of Temasek Trust, has led a US$1.2 million funding round in Singapore-based AI healthtech startup injewelme, C3H said in a press release on Wednesday.

As digital transformation accelerates across industries, Singapore’s private healthcare sector is facing a critical bottleneck: while medical innovation and digital tools are advancing rapidly, the underlying infrastructure connecting providers, insurers, and patients remains fragmented.